Novozymes A/S (OTCMKTS:NVZMY) Share Price Crosses Below 200-Day Moving Average - Time to Sell?

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $62.47 and traded as low as $55.71. Novozymes A/S shares last traded at $55.74, with a volume of 17,179 shares.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on NVZMY shares. Citigroup lowered shares of Novozymes A/S from a "neutral" rating to a "sell" rating in a research report on Thursday, October 17th. Barclays raised shares of Novozymes A/S to a "strong-buy" rating in a research report on Monday, November 18th.

Novozymes A/S Stock Down 2.3 %

The stock has a market cap of $26.10 billion, a price-to-earnings ratio of 35.28, a price-to-earnings-growth ratio of 3.87 and a beta of 0.87. The company's 50-day moving average is $57.21 and its 200-day moving average is $62.48.

Novozymes A/S Company Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.